In the scientific center "Vector" are large-scale preclinical studies of a new vaccine. According to forecasts, the drug from the coronavirus will be fully ready by mid-September. About its effectiveness in an interview Naila Asker-zade said the head of Rospotrebnadzor Anna Popova.